Introduction: Neuroblastoma is one of the most common childhood cancers with one of the lowest survival rates, accounting for 15% of childhood cancer mortality. Approximately half of children treated for high-risk neuroblastoma will relapse following remission, while another 15% of patients do not respond to initial treatment. External beam radiation is infrequently used for treatment of pediatric cancer such as neuroblastoma, typically reserved for palliative care in patients with aggressive metastatic disease who fail to respond to alternative treatments. Understanding effects of radiation on neuroblastoma cells could improve efficacy of this final means of therapy to decrease tumor burden and stabilize the disease. Methods: In this study, we found that two microRNAs with opposite functions were expressed in two neuroblastoma cell lines with marked differences in radiosensitivity. Clonogenic assays were used to evaluate the radiation responses for these 2 cell lines, designated SK-N-AS and SK-N-DZ; cells were then irradiated at doses that cause 90% cell killing based on clonogenic assay and their RNA isolated and subjected to microarray analysis. In addition, cells were transfected with pre-miRNA constructs that led to overexpression of microRNAs miR-34a and miR-1228 to determine possible microRNA regulation of radiation response. Results: Statistically significant differences were detected for expression of several thousand genes when the 2 cell lines were compared with each other. In comparison, radiation exposure resulted in only minor gene expression differences of less than 2-fold at the 1 h postirradiation timepoint in both cell lines. Overexpression of miR-34a and miR-1228 in either cell line did not alter this outcome. Discussion: While these two neuroblastoma cell lines are phenotypically diverse and gene expression differences between them are extensive, we observed that the regulation of gene expression in both cell lines is in a stable equilibrium at early timepoints after exposure to ionizing radiation.

1.
Johnsen
JI
,
Dyberg
C
,
Wickström
M
.
Neuroblastoma-A neural crest derived embryonal malignancy
.
Front Mol Neurosci
.
2019
;
12
:
9
.
2.
Brodeur
GM
,
Seeger
RC
,
Schwab
M
,
Varmus
HE
,
Bishop
JM
.
Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage
.
Science
.
1984 Jun 8
224
4653
1121
4
.
3.
Seeger
RC
,
Brodeur
GM
,
Sather
H
,
Dalton
A
,
Siegel
SE
,
Wong
KY
.
Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas
.
N Engl J Med Overseas Ed
.
1985 Oct 31
313
18
1111
6
.
4.
Pugh
TJ
,
Morozova
O
,
Attiyeh
EF
,
Asgharzadeh
S
,
Wei
JS
,
Auclair
D
.
The genetic landscape of high-risk neuroblastoma
.
Nat Genet
.
2013 Mar
45
3
279
84
.
5.
Sokol
E
,
Desai
AV
.
The evolution of risk classification for neuroblastoma
.
Children
.
2019 Feb 11
6
2
27
.
6.
Matthay
KK
,
Maris
JM
,
Schleiermacher
G
,
Nakagawara
A
,
Mackall
CL
,
Diller
L
Nat Rev Dis Primers
.
2016 Nov 10
2
1
16078
.
7.
Campbell
K
,
Kao
PC
,
Naranjo
A
,
Kamijo
T
,
Ramanujachar
R
,
London
WB
.
Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: a report from the International Neuroblastoma Risk Group (INRG) project
.
Pediatr Blood Cancer
.
2022 Oct 31
70
2
e30054
.
8.
Cornelissen
J
,
Van Kuilenburg
AB
,
Voûte
PA
,
Van Gennip
AH
.
MIBG causes oxidative stress and up-regulation of anti-oxidant enzymes in the human neuroblastoma cell line SK-N-BE(2c)
.
Int J Cancer
.
1997 Jul 29
72
3
486
90
.
9.
Wilson
JS
,
Gains
JE
,
Moroz
V
,
Wheatley
K
,
Gaze
MN
.
A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma
.
Eur J Cancer
.
2014 Mar
50
4
801
15
.
10.
Haas-Kogan
DA
,
Swift
PS
,
Selch
M
,
Haase
GM
,
Seeger
RC
,
Gerbing
RB
.
Impact of radiotherapy for high-risk neuroblastoma: a Children’s Cancer Group study
.
Int J Radiat Oncol Biol Phys
.
2003 May 1
56
1
28
39
.
11.
Oeffinger
KC
,
Mertens
AC
,
Sklar
CA
,
Kawashima
T
,
Hudson
MM
,
Meadows
AT
.
Chronic health conditions in adult survivors of childhood cancer
.
N Engl J Med Overseas Ed
.
2006 Oct 12
355
15
1572
82
.
12.
Ciccarone
V
,
Spengler
BA
,
Meyers
MB
,
Biedler
JL
,
Ross
RA
.
Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages
.
Cancer Res
.
1989 Jan 1
49
1
219
25
.
13.
Gautier
M
,
Thirant
C
,
Delattre
O
,
Janoueix-Lerosey
I
.
Plasticity in neuroblastoma cell identity defines a noradrenergic-to-mesenchymal transition (NMT)
.
Cancers
.
2021 Jun 10
13
12
2904
.
14.
Corey
JM
,
Gertz
CC
,
Sutton
TJ
,
Chen
Q
,
Mycek
KB
,
Wang
BS
.
Patterning N-type and S-type neuroblastoma cells with Pluronic F108 and ECM proteins
.
J Biomed Mater Res A
.
2010 May
93
2
673
86
.
15.
Campos Cogo
S
,
Gradowski Farias da Costa do Nascimento
T
,
de Almeida Brehm Pinhatti
F
,
de França Junior
N
,
Santos Rodrigues
B
,
Cavalli
LR
.
An overview of neuroblastoma cell lineage phenotypes and in vitro models
.
Exp Biol Med
.
2020 Dec
245
18
1637
47
.
16.
Sandoval
JA
,
Hoelz
DJ
,
Woodruff
HA
,
Powell
RL
,
Jay
CL
,
Grosfeld
JL
.
Novel peptides secreted from human neuroblastoma: useful clinical tools
.
J Pediatr Surg
.
2006 Jan
41
1
245
51
.
17.
Zins
K
,
Schäfer
R
,
Paulus
P
,
Dobler
S
,
Fakhari
N
,
Sioud
M
.
Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering with β-catenin-dependent and β-catenin-independent signaling pathways
.
Oncotarget
.
2016 Jul 19
7
29
46187
202
.
18.
Hanmod
SS
,
Wang
G
,
Edwards
H
,
Buck
SA
,
Ge
Y
,
Taub
JW
.
Targeting histone deacetylases (HDACs) and Wee1 for treating high-risk neuroblastoma
.
Pediatr Blood Cancer
.
2015 Jan
62
1
52
9
.
19.
Dower
CM
,
Bhat
N
,
Gebru
MT
,
Chen
L
,
Wills
CA
,
Miller
BA
.
Targeted inhibition of ULK1 promotes apoptosis and suppresses tumor growth and metastasis in neuroblastoma
.
Mol Cancer Ther
.
2018 Nov
17
11
2365
76
.
20.
Yu
Y
,
Ding
J
,
Zhu
S
,
Alptekin
A
,
Dong
Z
,
Yan
C
.
Therapeutic targeting of both dihydroorotate dehydrogenase and nucleoside transport in MYCN-amplified neuroblastoma
.
Cell Death Dis
.
2021 Aug 30
12
9
821
.
21.
Ambros
PF
,
Ambros
IM
,
Brodeur
GM
,
Haber
M
,
Khan
J
,
Nakagawara
A
.
International consensus for neuroblastoma molecular diagnostics: report from the international neuroblastoma risk group (INRG) biology committee
.
Br J Cancer
.
2009 May 5
100
9
1471
82
.
22.
Kreissman
SG
,
Seeger
RC
,
Matthay
KK
,
London
WB
,
Sposto
R
,
Grupp
SA
.
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
.
Lancet Oncol
.
2013 Sep
14
10
999
1008
.
23.
Ho
N
,
Peng
H
,
Mayoh
C
,
Liu
PY
,
Atmadibrata
B
,
Marshall
GM
.
Delineation of the frequency and boundary of chromosomal copy number variations in paediatric neuroblastoma
.
Cell Cycle
.
2018
;
17
(
6
):
749
58
.
24.
Cole
KA
,
Attiyeh
EF
,
Mosse
YP
,
Laquaglia
MJ
,
Diskin
SJ
,
Brodeur
GM
.
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene
.
Mol Cancer Res
.
2008 May
6
5
735
42
.
25.
Liu
W
,
Mirzoeva
S
,
Yuan
Y
,
Deng
J
,
Chen
S
,
Lai
B
.
Development of Fe(3)O(4) core-TiO(2) shell nanocomposites and nanoconjugates as a foundation for neuroblastoma radiosensitization
.
Cancer Nanotechnol
.
2021
;
12
(
1
):
12
.
26.
De Antonellis
P
,
Carotenuto
M
,
Vandenbussche
J
,
De Vita
G
,
Ferrucci
V
,
Medaglia
C
.
Early targets of miR-34a in neuroblastoma
.
Mol Cell Proteomics
.
2014 Aug
13
8
2114
31
.
27.
Okada
N
,
Lin
CP
,
Ribeiro
MC
,
Biton
A
,
Lai
G
,
He
X
.
A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression
.
Genes Dev
.
2014 Mar 1
28
5
438
50
.
28.
Ma
W
,
Xiao
GG
,
Mao
J
,
Lu
Y
,
Song
B
,
Wang
L
.
Dysregulation of the miR-34a-SIRT1 axis inhibits breast cancer stemness
.
Oncotarget
.
2015 Apr 30
6
12
10432
44
.
29.
Glinsky
GV
,
Krones-Herzig
A
,
Glinskii
AB
.
Malignancy-associated regions of transcriptional activation: gene expression profiling identifies common chromosomal regions of a recurrent transcriptional activation in human prostate, breast, ovarian, and colon cancers
.
Neoplasia
.
2003 May-Jun
5
3
218
28
.
30.
Su
WT
,
Alaminos
M
,
Mora
J
,
Cheung
NK
,
La Quaglia
MP
,
Gerald
WL
.
Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas
.
Cancer Genet Cytogenet
.
2004 Oct 15
154
2
131
7
.
31.
Fischer
U
,
Leidinger
P
,
Keller
A
,
Folarin
A
,
Ketter
R
,
Graf
N
.
Amplicons on chromosome 12q13-21 in glioblastoma recurrences
.
Int J Cancer
.
2010 Jun 1
126
11
2594
602
.
32.
Schumacher
FR
,
Berndt
SI
,
Siddiq
A
,
Jacobs
KB
,
Wang
Z
,
Lindstrom
S
.
Genome-wide association study identifies new prostate cancer susceptibility loci
.
Hum Mol Genet
.
2011 Oct 1
20
19
3867
75
.
33.
Stanisavljevic
D
,
Petrovic
I
,
Vukovic
V
,
Schwirtlich
M
,
Gredic
M
,
Stevanovic
M
.
SOX14 activates the p53 signaling pathway and induces apoptosis in a cervical carcinoma cell line
.
PLoS One
.
2017
;
12
(
9
):
e0184686
.
34.
Gautier
L
,
Cope
L
,
Bolstad
BM
,
Irizarry
RA
.
affy: analysis of Affymetrix GeneChip data at the probe level
.
Bioinformatics
.
2004 Feb 12
20
3
307
15
.
35.
Bioconductor.
36.
R Core
Team
R: A language and environment for statistical computing
Vienna, Austria
R Foundation for Statistical Computing
.
37.
Dai
M
,
Wang
P
,
Boyd
AD
,
Kostov
G
,
Athey
B
,
Jones
EG
.
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data
.
Nucleic Acids Res
.
2005 Nov 10
33
20
e175
.
38.
Mecham
BH
,
Nelson
PS
,
Storey
JD
.
Supervised normalization of microarrays
.
Bioinformatics
.
2010 May 15
26
10
1308
15
.
39.
Ritchie
ME
,
Phipson
B
,
Wu
D
,
Hu
Y
,
Law
CW
,
Shi
W
.
Limma powers differential expression analyses for RNA-sequencing and microarray studies
.
Nucleic Acids Res
.
2015 Apr 20
43
7
e47
.
40.
Phipson
B
,
Lee
S
,
Majewski
IJ
,
Alexander
WS
,
Smyth
GK
.
Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression
.
Ann Appl Stat
.
2016 Jun
10
2
946
63
.
41.
Raudvere
U
,
Kolberg
L
,
Kuzmin
I
,
Arak
T
,
Adler
P
,
Peterson
H
.
g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)
.
Nucleic Acids Res
.
2019 Jul 2
47
W1
W191
8
.
42.
Sokolov
MV
,
Panyutin
IV
,
Neumann
RD
.
Unraveling the global microRNAome responses to ionizing radiation in human embryonic stem cells
.
PLoS One
.
2012
;
7
(
2
):
e31028
.
43.
Berezikov
E
,
Chung
WJ
,
Willis
J
,
Cuppen
E
,
Lai
EC
.
Mammalian mirtron genes
.
Mol Cell
.
2007 Oct 26
28
2
328
36
.
44.
Welch
C
,
Chen
Y
,
Stallings
RL
.
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
.
Oncogene
.
2007 Jul 26
26
34
5017
22
.
45.
Tivnan
A
,
Tracey
L
,
Buckley
PG
,
Alcock
LC
,
Davidoff
AM
,
Stallings
RL
.
MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma
.
BMC Cancer
.
2011 Jan 25
11
33
.
46.
Cheng
X
,
Xu
Q
,
Zhang
Y
,
Shen
M
,
Zhang
S
,
Mao
F
.
miR-34a inhibits progression of neuroblastoma by targeting autophagy-related gene 5
.
Eur J Pharmacol
.
2019 May 5
850
53
63
.
47.
Ordóñez
R
,
Gallo-Oller
G
,
Martínez-Soto
S
,
Legarra
S
,
Pata-Merci
N
,
Guegan
J
.
Genome-wide microarray expression and genomic alterations by array-CGH analysis in neuroblastoma stem-like cells
.
PLoS One
.
2014
;
9
(
11
):
e113105
.
48.
Kandula
S
,
Prabhu
RS
,
Nanda
R
,
Switchenko
JM
,
Cash
T
,
Qayed
M
.
Outcomes after radiation therapy to metastatic sites in patients with stage 4 neuroblastoma
.
J Pediatr Hematol Oncol
.
2015 Apr
37
3
175
80
.
49.
Casey
DL
,
Kushner
BH
,
Cheung
NKV
,
Modak
S
,
LaQuaglia
MP
,
Wolden
SL
.
Dose-escalation is needed for gross disease in high-risk neuroblastoma
.
Pediatr Blood Cancer
.
2018 Jul
65
7
e27009
.
50.
Boeva
V
,
Louis-Brennetot
C
,
Peltier
A
,
Durand
S
,
Pierre-Eugène
C
,
Raynal
V
.
Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
.
Nat Genet
.
2017 Sep
49
9
1408
13
.
You do not currently have access to this content.